Media Centre
Latest press releases
-
Farxiga approved in the US for the treatment of paediatric type-2 diabetes
-
Tagrisso granted Priority Review in the US for patients with unresectable, Stage III EGFR-mutated lung cancer
-
Acquisition of Fusion completed
-
Tagrisso with the addition of chemotherapy recommended for approval in the EU by CHMP for patients with EGFR-mutated advanced lung cancer
-
Tagrisso reduced the risk of disease progression or death by 84% in patients with unresectable, Stage III EGFR-mutated lung cancer vs. placebo in LAURA Phase III trial
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.